Morning or evening administration of nasal calcitonin? Effects on biochemical markers of bone turnover (Q71956294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Morning or evening administration of nasal calcitonin? Effects on biochemical markers of bone turnover (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

3

C Hassager

1 reference

22 October 2019

A Schlemmer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

C Christiansen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

63-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Treatment of Paget's Disease of Bone with Synthetic Salmon Calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Thyrocalcitonin: effect on idiopathic hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Nasal salmon calcitonin in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Effect of salcatonin given intranasally on early postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Nasal calcitonin for treatment of established osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Changes in the carboxyl-terminal propeptide of type I procollagen and other markers of bone formation upon five days of bed rest

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

A sensitiviein vitro method for studying the induction and inhibition of bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Acute effects of nasal salmon calcitonin on calcium and bone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Effect of different doses of nasal salmon calcitonin on bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Intranasal calcitonin suppresses increased bone resorption during short-term immobilization: a double-blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

Human calcitonin in the treatment of Paget's bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2896%2900307-9

7 January 2021

10.1016/S8756-3282(96)00307-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8988349%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference